Analyst Ratings For Dova Pharmacuet (NASDAQ:DOVA)
Today, Leerink Swann initiated coverage on Dova Pharmacuet (NASDAQ:DOVA) with a Market Perform.
There are 1 hold rating, 1 buy rating on the stock.
The current consensus rating on Dova Pharmacuet (NASDAQ:DOVA) is Buy (Score: 2.50) with a consensus target price of $30.00 per share, a potential 31.87% upside.
Some recent analyst ratings include
- 7/24/2017-Leerink Swann initiated coverage with a Market Perform rating.
- 7/24/2017-Jefferies Group LLC initiated coverage with a Buy rating.
Recent Trading Activity for Dova Pharmacuet (NASDAQ:DOVA)
Shares of Dova Pharmacuet closed the previous trading session at 22.75 down -0.02 -0.09% with 138,727 shares trading hands.